Skip to main content

Day: January 4, 2022

Treatment to Expand Global Library of Medicine with Dermatologic Diseases

VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to the GLM, enhancing soon-to-be-released products such as the Treatment Mobile app, which is set for release this month. Kevin A. Peterson, MD, MPH, FRCS(Ed), FAAFP and Chief Medical Officer of Treatment, says, “Engaging in research with the University of Minnesota Dermatology department brings extensive academic medical expertise that enhances our ability...

Continue reading

First Citizens Completes Merger With CIT Group

Frank B. Holding Jr., First Citizens chairman and chief executive officer“This is a transformational milestone in our 124-year history,” Holding said.Ellen R. Alemany, First Citizens vice chairwomanEllen R. Alemany, former chairwoman and chief executive officer of CIT, assumes the role of vice chairwoman of First Citizens (along with current First Citizens Vice Chairwoman Hope Holding Bryant) and will serve on the First Citizens Board of Directors.Michael A. CarpenterCarpenter will serve on the First Citizens BancShares Board of Directors.Vice Admiral John R. Ryan, USN (Ret.)Ryan will serve on the First Citizens BancShares Board of Directors.Marisa J. Harney, First Citizens chief credit officerHarney is now a member of the First Citizens executive leadership...

Continue reading

Annual General Meeting of RTX to be held on 27 January 2022

Noerresundby, Denmark, 4 January 2022Announcement no. 01/2022 Enclosed please find a notice convening the Annual General Meeting of RTX to be held on Thursday 27 January 2022 at 3.00 pm at the Company’s address: Stroemmen 6, Noerresundby. Best regards,RTX A/S Peter Røpke        CEO Questions and further information: Peter Røpke, CEO, tel. +45 96 32 23 00 Please visit RTX’s website at: www.rtx.dkAttachmentRTX CA No 01-2022 – 04.01.22 – Notice of AGM with agenda and complete proposals

Continue reading

UTStarcom Announces Progress in Cooperation with China Unicom Research Institute on Development of 5G Transport Network Solution

HANGZHOU, China, Jan. 04, 2022 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or the “Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today announced progress with China Unicom Research Institute in their cooperative development and field testing of a disaggregated networking solution for 5G transport networks. China Unicom Research Institute is a wholly owned subsidiary of China Unicom, one of the major mobile network operators (“MNO”) in China. As a relatively new technology, the disaggregation of hardware and software in telecommunication networks is drawing serious interest in the telecom industry, especially for 5G transport networks. Disaggregation promises many benefits, such as the potential to reduce the capital commitment and operating costs of transport networks, eliminating vendor lock-in, speeding...

Continue reading

Allena Pharmaceuticals Provides Clinical and Corporate Update

ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in first cohort of patients with hyperuricemia and chronic kidney disease in the Phase 2a Study 201Allena to host webinar to discuss the initial Study 201 data with Key Opinion Leaders Robert Terkeltaub, M.D. and David S. Goldfarb, M.D. today at 8:00 am ET; log-in information below ALLN-346 Phase 2a Study 202 is actively enrolling patients with gout and stages 2 and 3 chronic kidney disease in parallel cohorts; data from both cohorts expected in Q1 2022 Company currently evaluating potential modifications to the pivotal URIROX-2 Phase 3 trial of Reloxaliase in Enteric Hyperoxaluria in an effort to reduce the size and duration of...

Continue reading

Verizon and Google team up to help unlock value for remote workforces with BlueJeans on Glass Enterprise Edition 2 and Google Pixel

What you need to know:BlueJeans Meetings now comes preloaded on Glass Enterprise Edition 2 devices sold by Verizon Combination of Google Pixel, Glass Enterprise Edition 2 and BlueJeans Meetings unleashes new, hands-free way to visualize the world around you When powered by 5G mobile connectivity, Google Pixel 6 with BlueJeans Meetings on Glass maximizes productivity and minimizes error rates in frontline workersNEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — Verizon Business today announced BlueJeans Meetings is now available for Glass Enterprise Edition 2*. Coming soon, business customers can purchase Glass Enterprise Edition 2 with BlueJeans preloaded* from Verizon for $1,139.99 to integrate glass wearables into the new ways of working. For a limited time, customers can get up to $700 off Glass Enterprise Edition 2 when purchased...

Continue reading

At 15.6% CAGR, Vehicle Telematics Market Size [2022-2028] is Projected to Grow USD 179.50 Billion

Vehicle Telematics Market Key Companies Analyzed in this Report Are Robert Bosch GmbH (Gerlingen, Germany), Webfleet Solutions B.V. (Amsterdam, North Holland), MiX Telematics (Midrand, South Africa), Trimble (California, U.S.), Verizon (New York, U.S.), Zonar Systems (Washington, U.S.), Octo Group S.p.A (Rome, Italy), Microlise Telematics Pvt. Ltd. (Nottingham, U.K.), Omnitracs (Texas, U.S.), Masternaut Limited (London, U.K.). Pune, India, Jan. 04, 2022 (GLOBE NEWSWIRE) — According to the report by Fortune Business Insights, the global Vehicle Telematics market size was USD 58.69 billion in 2020. The market is projected to grow from USD 64.93 billion in 2021 to USD 179.50 billion in 2028 growing at a CAGR of 15.6% over the forecast period. The rising demand for smartphone characteristics in the automobile, automated driving technologies...

Continue reading

Turnover of Apranga Group in December 2021 and total year 2021

The retail turnover (including VAT) of Apranga Group amounted to EUR 25.6 million in December 2021 and has increased by 87.0% in comparison to December 2020. Due to epidemic coronavirus (COVID-19) infection, from 16 December 2020, all the Group’s stores in Lithuania were temporarily closed. Stores in Lithuania with a separate entrance from outside and a sales area not exceeding 300 square meters had been open since 15 February 2021. All stores with a separate entrance from outside had been open since 15 March 2021. All Group’s stores have been reopened in Lithuania from 19 April 2021, however, stores operating in shopping malls were not allowed to work on weekends, unless they had separate entrance from outside. Eventually, all Group’s stores have been open in Lithuania as of 29 May 2021. In Latvia, stores were temporarily closed from...

Continue reading

POC Coagulation Testing Devices Market Size [2022-2028] | is Estimated to Reach USD 2.44 Billion in 2028 with 6.9% CAGR

Key Companies in POC Coagulation Testing Devices Market are Werfen (Barcelona, Spain), CoaguSense, Inc. (California, U.S.), Helena Laboratories Corporation (Texas, U.S.), Medtronic (Dublin, Ireland), Abbott (Illinois, U.S.), F. Hoffmann-La Roche Ltd (Basel, Switzerland), Siemens Healthcare GmbH (Munich, Germany), Koninklijke Philips N.V. (Amsterdam, Netherlands), HemoSonics, LLC (Virginia, U.S.), Haemonetics Corporation (Boston, U.S.) Pune, India, Jan. 04, 2022 (GLOBE NEWSWIRE) — The global POC Coagulation Testing Devices Market size is estimated to reach USD 2.44 billion in 2028. The market size was USD 1.50 billion in 2020 whereas it is estimated to be USD 1.53 billion in 2021. Furthermore, the market registered a CAGR of 6.9% in the 2021-2028 period. This information is provided by Fortune Business Insights™, in its report,...

Continue reading

Total Assets Value

  PayPoint Plc (the “Company”) – Total Voting Rights       In conformity with DTR 5.6.1 the Company hereby notifies the market of the following:   As at 31 December 2021, the Company’s capital consisted of 68,747,474 ordinary shares with voting rights.   The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.     Enquiries:   PayPoint Plc            Sarah Carne, Company Secretary               +44(0)1707 600300  LEI: 5493004YKWI8U0GDD138     http://corporate.paypoint.com/    

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.